Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-... by Diaz, Luis A, MD, Shiu, Kai-Keen, MD, Kim, Tae-Won, MD, Jensen, Benny Vittrup, MD, Jensen, Lars Henrik, MD, Punt, Cornelis, MD, Smith, Denis, MD, Garcia-Carbonero, Rocio, MD, Benavides, Manuel, MD, Gibbs, Peter, MD, de la Fourchardiere, Christelle, MD, Rivera, Fernando, MD, Elez, Elena, MD, Le, Dung T, MD, Yoshino, Takayuki, MD, Zhong, Wen Yan, PhD, Fogelman, David, MD, Marinello, Patricia, PharmD, Andre, Thierry, MD

Get full text

Trastuzumab deruxtecan (DS-8201) in patients with HER2-expressing metastatic colorectal cancer (DESTINY-CRC01): a multicentre, open-label, phase 2 trial by Siena, Salvatore, MD, Di Bartolomeo, Maria, MD, Raghav, Kanwal, MD, Masuishi, Toshiki, MD, Loupakis, Fotios, MD, Kawakami, Hisato, MD, Yamaguchi, Kensei, MD, Nishina, Tomohiro, MD, Fakih, Marwan, MD, Elez, Elena, MD, Rodriguez, Javier, MD, Ciardiello, Fortunato, MD, Komatsu, Yoshito, MD, Esaki, Taito, MD, Chung, Ki, MD, Wainberg, Zev, MD, Sartore-Bianchi, Andrea, MD, Saxena, Kapil, MD, Yamamoto, Eriko, BSPS, Bako, Emarjola, MD, Okuda, Yasuyuki, MPH, Shahidi, Javad, MD, Grothey, Axel, MD, Yoshino, Takayuki, MD

Get full text

Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab vers... by Andre, Thierry, MD, Amonkar, Mayur, PhD, Norquist, Josephine M, MS, Shiu, Kai-Keen, FRCP, Kim, Tae Won, MD, Jensen, Benny Vittrup, MD, Jensen, Lars Henrik, PhD, Punt, Cornelis J A, MD, Smith, Denis, MD, Garcia-Carbonero, Rocio, MD, Sevilla, Isabel, MD, De La Fouchardiere, Christelle, MD, Rivera, Fernando, MD, Elez, Elena, MD, Diaz, Luis A, MD, Yoshino, Takayuki, MD, Van Cutsem, Eric, MD, Yang, Ping, PhD, Farooqui, Mohammed, DO, Le, Dung T, MD

Get full text

Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial by Subbiah, Vivek, MD, Lassen, Ulrik, Prof, Élez, Elena, MD, Italiano, Antoine, Prof, Curigliano, Giuseppe, Prof, Javle, Milind, Prof, de Braud, Filippo, Prof, Prager, Gerald W, Prof, Greil, Richard, Prof, Stein, Alexander, MD, Fasolo, Angelica, MD, Schellens, Jan H M, Prof, Wen, Patrick Y, Prof, Viele, Kert, PhD, Boran, Aislyn D, PhD, Gasal, Eduard, MD, Burgess, Paul, MSci, Ilankumaran, Palanichamy, PhD, Wainberg, Zev A, Prof

Get full text

Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2... by Strickler, John H, MD, Cercek, Andrea, MD, Siena, Salvatore, Prof, André, Thierry, Prof, Ng, Kimmie, MD, Van Cutsem, Eric, Prof, Wu, Christina, Prof, Paulson, Andrew S, MD, Hubbard, Joleen M, MD, Coveler, Andrew L, MD, Fountzilas, Christos, MD, Kardosh, Adel, MD, Kasi, Pashtoon M, MD, Lenz, Heinz-Josef, Prof, Ciombor, Kristen K, MD, Elez, Elena, MD, Bajor, David L, MD, Cremolini, Chiara, MD, Sanchez, Federico, MD, Stecher, Michael, MD, Feng, Wentao, PhD, Bekaii-Saab, Tanios S, Prof

Get full text